Ftse Mib
35.377,78
-0,09%
DAX
18.667,11
-0,31%
S&P 500
5.297,10
-0,21%
NASDAQ
16.698,32
-0,26%
Bitcoin
66.447,72
1,85%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Rafael Holdings Inc (RFL) Rafael Holdings Inc (RFL) Notizie

RFL

Rafael (RFL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:RFL
DataOraFonteTitoloSimboloCompagnia
06/10/202112:30PR Newswire (US)Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical OfficerAMEX:RFLRafael Holdings Inc
17/09/202122:01PR Newswire (US)Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08AMEX:RFLRafael Holdings Inc
20/08/202113:00PR Newswire (US)Rafael Holdings Announces $104.2 Million Private PlacementAMEX:RFLRafael Holdings Inc
17/08/202116:11PR Newswire (US)Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics CompanyAMEX:RFLRafael Holdings Inc
30/06/202114:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present Pancreatic & Biliary Tract Cancer Data on CPI-613® (Devimistat) from its Multicenter, Rand...AMEX:RFLRafael Holdings Inc
29/06/202117:00GlobeNewswire Inc.FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary CancerAMEX:RFLRafael Holdings Inc
23/06/202118:39PR Newswire (US)Rafael Holdings and Rafael Pharmaceuticals Management Presented at the Raymond James 2021 Human Health Innovation Conference ...AMEX:RFLRafael Holdings Inc
26/05/202115:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the...AMEX:RFLRafael Holdings Inc
30/03/202115:00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Enrollment of 150 Patients in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) fo...AMEX:RFLRafael Holdings Inc
19/01/202117:30GlobeNewswire Inc.Rafael Pharmaceuticals to Present at B. Riley Securities Virtual Oncology Investor ConferenceAMEX:RFLRafael Holdings Inc
13/01/202115:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare ConferenceAMEX:RFLRafael Holdings Inc
22/12/202014:30PR Newswire (US)Barer Institute Announces Licensing Agreement with Princeton University's Office of Technology Licensing for SHMT Inhibitor P...AMEX:RFLRafael Holdings Inc
15/12/202017:09GlobeNewswire Inc.UPDATE - Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Mye...AMEX:RFLRafael Holdings Inc
15/12/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leuk...AMEX:RFLRafael Holdings Inc
01/12/202018:05GlobeNewswire Inc.Rafael Pharmaceuticals Partners with Sara’s Cure and SARC for the Launch of Phase 2 Clinical Trial for CPI-613® (devimista...AMEX:RFLRafael Holdings Inc
10/11/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Pancreatic CancerAMEX:RFLRafael Holdings Inc
29/10/202014:30GlobeNewswire Inc.FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (devimistat) for Treatment of Soft Tissue SarcomaAMEX:RFLRafael Holdings Inc
27/10/202014:00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Enrollment of 100th Patient in Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) f...AMEX:RFLRafael Holdings Inc
20/10/202015:00GlobeNewswire Inc.A New Phase 1 Study Began to Evaluate Rafael Pharmaceuticals’ Lead Compound CPI-613®️ (devimistat) for Patients With Pan...AMEX:RFLRafael Holdings Inc
24/08/202014:30PR Newswire (US)Rafael Holdings to Present at LD Micro Investor ConferenceAMEX:RFLRafael Holdings Inc
06/08/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ®️ (de...AMEX:RFLRafael Holdings Inc
21/07/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Crosses Midpoint of Enrollment to First Interim Analysis in Pivotal Phase 3 Trial (ARMADA 2000) of CPI...AMEX:RFLRafael Holdings Inc
09/06/202023:28PR Newswire (US)Rafael Holdings Reports Third Quarter Fiscal Year 2020 ResultsAMEX:RFLRafael Holdings Inc
09/06/202023:25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:RFLRafael Holdings Inc
09/06/202023:17Edgar (US Regulatory)Quarterly Report (10-q)AMEX:RFLRafael Holdings Inc
26/05/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals to Present Phase 1 Data on CPI-613® (Devimistat) in Patients with Locally Advanced or Metastatic Panc...AMEX:RFLRafael Holdings Inc
07/05/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Announces In Vivo Study to Evaluate the Effects of CPI-613® (Devimistat) in Combination with Azacitid...AMEX:RFLRafael Holdings Inc
05/05/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Enters into Research Collaboration with Roswell Park Comprehensive Cancer Center to Evaluate the Effec...AMEX:RFLRafael Holdings Inc
28/04/202015:00GlobeNewswire Inc.MD Anderson Cancer Center Now Enrolling Patients in Rafael Pharmaceuticals’ Phase 2 Clinical Trial of CPI-613® (devimistat...AMEX:RFLRafael Holdings Inc
23/04/202015:00GlobeNewswire Inc.Rafael Pharmaceuticals Receives Approvals to Open Trial Sites in India and Canada for Pivotal Phase 3 Trial (ARMADA 2000) of ...AMEX:RFLRafael Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:RFL

La tua Cronologia

NYSE
RIV.RT
RiverNorth Opportunities
COIN
DESBTC
LSE
FTNE
Granite Fatang
LSE
64CL
Natwest 6.625%
NYSE
AJXA
Great Ajax
CRTO
WEMIXUSDT
WEMIX TOKEN
COIN
AMAAAUST
AMAUROT
LSE
BK56
Stand.chart.30
KUCN
MTNETH
MedToken
USOTC
CANB
CAN B (QB)
LSE
3SVE
Granite 3s Nvda
NASDAQ
VRME
VerifyMe
USOTC
PMDKF
Pt Mitra Adiperkasa Tbk (PK)
LSE
UZ94
Mitsu Hc Cap.23
NYSE
ROSS
Ross Acquisition Corp II
AQSE
KNDR
Kondor AI
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network